Metraipolis › archive › dc_3cc924c2dcdc

PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models — Europe PMC PMID:41501884

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41501884
DOI
10.1186/s13046-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-06T23:55:24.359Z
SHA-256 of the archived text
9d11f21f6da9930f1d1821db0dcaebf8d097073e562c0b118eb452104f82bae4
Stable URL of this page
https://metraipolis.com/documento/dc_3cc924c2dcdc

How to cite

PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models — Europe PMC PMID:41501884 — Europe PMC (en), https://europepmc.org/article/MED/41501884 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3cc924c2dcdc (Metraipolis archive dc_3cc924c2dcdc, sha256 9d11f21f6da9930f1d1821db0dcaebf8d097073e562c0b118eb452104f82bae4)
BibTeX
@misc{dc3cc924c2dcdc,
  title = {PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models — Europe PMC PMID:41501884},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41501884},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3cc924c2dcdc; sha256 9d11f21f6da9930f1d1821db0dcaebf8d097073e562c0b118eb452104f82bae4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41501884. Agents can read the archived copy with the MCP tool read_document.